Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.16

Mkt cap

59M

Volume

18K

High

0.16

P/E Ratio

-5.17

52-wk high

0.39

Low

0.15

Div yield

N/A

52-wk low

0.14

The article lists the cannabis stocks that gained and lost on August 14, 2023. Some of the biggest gainers include Choom Holdings, Zynerba Pharmaceuticals, and Maple Leaf Green World. On the other hand, Red White & Bloom Brands, GrowLife, and Tetra Bio Pharma were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 9:30 pm

The article lists the cannabis stocks that gained and lost on August 11, 2023. Notable gainers include Australis Capital (OTC:AUSAF), StateHouse Hldgs (OTC:STHZF), and Hemp (OTC:HEMP). Significant losers include Chalice Brands (OTC:CHALF), Radient Technologies (OTC:RDDTF), and Maple Leaf Green World (OTC:MGWFF).

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 9:30 pm

The article lists the cannabis stocks that gained and lost on August 10, 2023. The biggest gainers were Choom Holdings (OTC:CHOOF), Item 9 Labs (OTC:INLB), and Delivra Health Brands (OTC:DHBUF), while the biggest losers were CannTrust Holdings (OTC:CNTTQ), SciSparc (NASDAQ:SPRC), and Khiron Life Sciences (OTC:KHRNF).

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 9:30 pm

The article lists the marijuana stocks that gained and lost on August 8, 2023. Notable gainers include Rocky Mountain High (OTC:RMHB), Earth Science Tech (OTC:ETST), and Tilray Brands (NASDAQ:TLRY). Major losers include Choom Holdings (OTC:CHOOF), CLS Holdings USA (OTC:CLSH), and Maple Leaf Green World (OTC:MGWFF).

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 9:30 pm

Marijuana stocks experienced a bearish Monday with several stocks seeing significant changes. Top gainers included Gaby, Panacea Life Sciences, Avicanna, SLANG Worldwide, and Grown Rogue International. Major losers included EVIO, Item 9 Labs, Target Group, Malachite Innovations, and Rocky Mountain High.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:30 pm

On August 3, 2023, several cannabis stocks experienced significant price movements. Notable gainers included Choom Holdings, Chalice Brands, and Hemp, with shares closing up 24900.00%, 9900.00%, and 100.00% respectively. On the other hand, MJ Holdings, SOL Global Investments, and Delivra Health Brands were among the biggest losers, with shares closing down 19.40%, 12.91%, and 11.76% respectively.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 2:42 pm

MariMed Inc. reported Q2 FY23 revenue of $36.5 million, a 10.7% YoY increase. However, adjusted EBITDA decreased by 29.4% to $6.3 million. The company also reported a net loss of $935,000 compared to income of $1.9 million in Q2 2022. MariMed's CEO highlighted the company's 14th consecutive quarter of positive adjusted EBITDA and strong balance sheet. The company expects 2023 revenue of at least $150 million and adjusted EBITDA of $32 million to $35 million.

Portfolio Pulse from Vuk Zdinjak

August 04, 2023 | 1:12 pm

MariMed reported Q2 sales of $36.52 million, beating the analyst consensus estimate of $35.50 million by 2.87 percent. This represents a 10.71 percent increase over sales of $32.99 million in the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 04, 2023 | 12:27 pm

A recent equity report by Zuanic & Associates reveals the tax payments and liabilities of 16 Multi-State Operators (MSOs) in the cannabis industry during CY22. The MSOs collectively paid $761 million in income taxes, with Curaleaf (OTC:CURLF) and Trulieve (OTC:TCNNF) being the top contributors. The report also highlights the varying income tax to gross profit ratios among the MSOs, suggesting that some companies might be using tax debts as a low-cost funding source.

Portfolio Pulse from Nicolás Jose Rodriguez

August 04, 2023 | 9:10 am

MariMed Inc. (OTCQX:MRMD) has filed a lawsuit against Nevada cultivation company The Harvest Foundation LLC for license violations and mismanagement of $2.4M in stock. MariMed alleges that Harvest's owners were responsible for actions leading to the revocation of the company's licenses by the Nevada Cannabis Compliance Board (NCCB) in 2021. MariMed is seeking damages and the return of one million shares of MariMed stock issued to Harvest's owners as part of a sale agreement.

Portfolio Pulse from Joana Scopel

August 04, 2023 | 9:08 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.